AltrixBio is an early-stage company focused on advancing our lead platform: LuCI™ AJN 003, an oral drug that replicates the metabolic success of bariatric surgery in treated of Type 2 Diabetes.
Bristol-Myers Squibb
310 followers
Astellas Pharma
59 followers
NYU Langone Health
48 followers
West Pharmaceutical Services
12 followers
Curia Global
9 followers
AbbVie
351 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
5 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
9 followers